NCT06291857Phase 3Completed

A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Study sponsor: Novavax

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-12-24Actual
Enrollment · participants9320Actual
Source updated2026-06-05Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 26 Jul 2026. After: 24 Dec 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview